Characterization of homologous and heterologous adaptive immune responses in porcine reproductive and respiratory syndrome virus infection
about
Review on the transmission porcine reproductive and respiratory syndrome virus between pigs and farms and impact on vaccinationApplying Convergent Immunity to Innovative Vaccines Targeting Staphylococcus aureus.Comparison of the efficacy of autogenous inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccines with that of commercial vaccines against homologous and heterologous challenges.Elevated dietary zinc oxide levels do not have a substantial effect on porcine reproductive and respiratory syndrome virus (PPRSV) vaccination and infectionIntegrative model of the immune response to a pulmonary macrophage infection: what determines the infection duration?Concentration and pattern changes of porcine serum apolipoprotein A-I in four different infectious diseases.Efficacy of Fostera PRRS modified live virus vaccine against a Canadian heterologous virulent field strain of porcine reproductive and respiratory syndrome virus.Vaccination of sows against type 2 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) before artificial insemination protects against type 2 PRRSV challenge but does not protect against type 1 PRRSV challenge in late gestationDistinct functional enrichment of transcriptional signatures in pigs with high and low IFN-gamma responses after vaccination with a porcine reproductive and respiratory syndrome virus (PRRSV).Immune Control of PRRS: Lessons to be Learned and Possible Ways Forward.Predicted peptides from non-structural proteins of porcine reproductive and respiratory syndrome virus are able to induce IFN-γ and IL-10.Fresh Pork and Porcine Reproductive and Respiratory Syndrome Virus: Factors Related to the Risk of Disease Transmission.Modified-live PRRSV subtype 1 vaccine UNISTRAIN® PRRS provides a partial clinical and virological protection upon challenge with East European subtype 3 PRRSV strain Lena.
P2860
Q28071014-C459E23A-7763-40FC-A71D-1C4ED18E1C38Q34250054-F0D44B0B-893F-495D-B3D9-8ED8167327B3Q34432119-91F83B7C-744C-477C-B15D-A858B746D4FAQ34624669-C49DB06B-1D9A-4E18-B478-C4643F069B35Q35261418-D3FA25C0-4545-460C-97B6-D292FF88887FQ35401433-46766737-7551-44ED-9DF6-21965D074F6BQ36390103-54F2ED65-DA85-48D7-A645-BB9BD480FBD1Q37582096-0C9FF52E-1520-4DC8-BF94-5DAD25D927D4Q38441596-5C6EDD81-184E-4B13-90E7-45B8FE9F9040Q38668708-8092DD9F-8AC6-429E-BA9B-CE3BD52C8FA5Q40259551-C39359B4-4B02-48BC-A2D0-4D8234CDFD9FQ42248419-D0C8731D-C53A-4A09-A1C2-5B110345702CQ54406243-C61F498B-CB91-4B70-B50B-4505723807A6
P2860
Characterization of homologous and heterologous adaptive immune responses in porcine reproductive and respiratory syndrome virus infection
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Characterization of homologous ...... atory syndrome virus infection
@en
Characterization of homologous ...... atory syndrome virus infection
@nl
type
label
Characterization of homologous ...... atory syndrome virus infection
@en
Characterization of homologous ...... atory syndrome virus infection
@nl
prefLabel
Characterization of homologous ...... atory syndrome virus infection
@en
Characterization of homologous ...... atory syndrome virus infection
@nl
P2093
P2860
P356
P1433
P1476
Characterization of homologous ...... atory syndrome virus infection
@en
P2093
Ivan Galindo
Joan Pujols
Joaquim Segalés
Laila Darwich
Liudmila Kuzemtseva
Margarita Martín
Mariona Gimeno
Nuria Navarro
Sergio López
P2860
P2888
P356
10.1186/1297-9716-43-30
P50
P577
2012-04-19T00:00:00Z
P6179
1030052161